Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Cyprus

European Research Council grant · Running

MechanoImmunoMap Immunity under Pressure: Mapping Compression Driven Tumor–Immune Rewiring to Potentiate Immunotherapy in Pancreatic Cancer

Coordinator
University of Cyprus, Cyprus
Runs
1 February 2027 to 31 January 2032
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101300346

What the project is doing

In the project's own words, from its summary on CORDIS.

Pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense, stiff stroma and elevated compressive forces within its tumor microenvironment, yet mechanical abnormalities are overlooked in treatment decisions. My prior work has shown that compression reprograms PDAC cells, activating pathways that drive migration and chemotherapy resistance. While chemotherapy remains the standard of care, its toxicity and limited survival benefits highlight the need for alternatives, such as immunotherapies, which harness the immune system but show minimal efficacy in PDAC.

My preliminary data indicate that compression drives immune evasion, metabolic rewiring, and an immunosuppressive niche, yet the mechanisms linking compressive stress to immunotherapy failure remain unresolved. MechanoImmunoMap integrates experimental and computational approaches to map how compressive forces reprogram tumor-immune interactions. Bioengineered 3D coculture models of tumor and immune cells under tunable compression, combined with multiomic profiling and mathematical modeling, will identify mechano-immunoregulatory pathways.

These pathways will be validated in vivo using mechanically characterized orthotopic PDAC models to build a comprehensive map of compression-driven tumor-immune rewiring. Linking mapped pathways to therapeutic target databases will identify drugs capable of counteracting compression-induced resistance. Prioritized drug candidates will be tested in vitro with immunotherapy and validated in vivo to deliver novel combination therapies that potentiate immunotherapy.

Finally, machine learning models will be employed to link compressive stress with multiomic tumor-immune profiling, establishing an engineering framework for immunotherapy response prediction. MechanoImmunoMap transforms compressive forces from a neglected barrier into a biomarker and therapeutic target, laying the foundation for mechanically informed precision oncology in PDAC and other solid tumors.

Topics

Who is involved

OrganisationCityCountryRole
University of CyprusNicosiaCyprusCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI